Do-Coop Drug Delivery Systems, Drug Development for the Pharma Industry

February 16, 2004: Do-Coop Technologies Announces Water-based Nano-reagent for Molecular Biology Research Tool Kits

 

OR-YEHUDA, Israel--(BUSINESS WIRE)--Feb. 16, 2004--Do-Coop Technologies announced today the general availability of NeowaterTM, a water-based reagent that is used for enhancing the performance of molecular biology tool kits for research. "We are very excited about the introduction of NeowaterTM, it is currently under evaluation with several customers and we have already gotten an enthusiastic response," said CTO Eran Gabbai. "Unlike conventional reagents, NeowaterTM is not application-specific and delivers significant performance enhancement as well as cost reduction in a variety of tool kits applications, and moreover, it is water-based so we are also helping to protect the environment," Gabbai said.

NeowaterTM can significantly improve the price-performance ratio in applications like nucleic acid or protein amplification and purification, cloning, transfection and transformation, cell cultures, competent cells, micro-arrays, substrate binding of oligonucleutides and proteins, Phage display, libraries, and more.

"NeowaterTM is first in a series of water-based Nano-reagents that Do-Coop Technologies will introduce to the molecular biology research tool kits market during 2004," said CEO Dr. Avi Messica. "Our pipeline also includes novel water-based products for the pharmaceutical industry that are currently under development," he added.

About Do-Coop Technologies

Founded in 1997, Do-Coop Technologies is a NanoBiotechnology company that has developed novel Nanotechnology to process water-based Nano-Reagents to deliver cost effective chemical and biological reactions. 

You can reach Do-Coop Technologies at http://www.docoop.com/ or info@docoop.com.

 

Drug development | Enzyme Stabilization | Protein Stabilization | PharmaPharmaceutical companies